DarioHealth Corp.

DarioHealth Corp.

NNASDAQ:DRIO
1.15
USD
-0.11
(-8.73%)
-5.49EPS
48.46MMarket Cap
Mar 10Next Earn

Total Valuation

USD

As of June 30, 2026, DarioHealth Corp. carries a market capitalization of 48.46M, placing it among publicly traded companies globally. Its enterprise value stands at 66.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap48.46M
Enterprise Value66.91M

Important Dates

DarioHealth Corp.'s next confirmed earnings release is scheduled for March 10, 2027.

Earnings Date3/10/2027

Share Statistics

As of June 30, 2026, DarioHealth Corp. has 7.34M shares outstanding.

Shares Outstanding7.34M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 2.04, and the price-to-book ratio stands at 0.88.

PS Ratio2.04
PB Ratio0.88
P/TBV Ratio-2.79
P/FCF Ratio-1.68
P/OCF Ratio-1.69

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 3.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 66.91M versus a market cap of 48.46M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.19

Financial Position

As of June 30, 2026, DarioHealth Corp. maintains a current ratio of 2.31, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 58.84, indicating elevated leverage, while an interest coverage ratio of -11.56 demonstrates limited ability to service its debt obligations.

Current Ratio2.31
Quick Ratio1.89
Debt / Equity58.84
Debt / EBITDA-0.62
Interest Coverage-11.56

Financial Efficiency

USD

Over the twelve months ended June 30, 2026, DarioHealth Corp. posted a negative return on equity (ROE) of -76.05, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -34.81, reflecting losses generated across the asset base. The company generates approximately 120,510.76 in revenue per employee across its workforce of 174.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.11 indicates how many times DarioHealth Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-76.05
Return on Assets (ROA)-34.81
Revenue Per Employee120,510.76
Employee Count174.25
Inventory Turnover2.11

Taxes

USD

Over the twelve months ended June 30, 2026, DarioHealth Corp. recorded 468,000.00 in income tax expense. The company reported a pretax loss of -35.20M and -35.67M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax468,000.00

Stock Price Statistics

USD

As of the close on November 16, 2026, DarioHealth Corp.'s stock has declined approximately 90.20% over the past 52 weeks. The 50-day moving average sits at 4.90, while the 200-day moving average is 7.23.

52-Week Price Change-90.20%
50-Day Moving Average4.90
200-Day Moving Average7.23

Income Statement

USD

Over the twelve months ended June 30, 2026, DarioHealth Corp. generated 21.00M in revenue and converted that into -35.67M in net income, yielding earnings per share of -5.49. EBITDA reached -52.31M, while operating income came in at -31.83M.

Revenue21.00M
Gross Profit12.21M
Operating Income-31.83M
Pretax Income-35.20M
Net Income-35.67M
EBITDA-52.31M
EBIT-54.43M
Earnings Per Share (EPS)-5.49

Balance Sheet

USD

As of June 30, 2026, DarioHealth Corp. holds 13.96M in cash and equivalents against 32.41M in total debt, resulting in a net debt position of 24.43M. Total book value stands at 55.09M, with working capital of 12.55M providing operational flexibility.

Cash & Cash Equivalents13.96M
Total Debt32.41M
Net Debt24.43M
Equity (Book Value)55.09M
Book Value Per Share7.50
Working Capital12.55M

Cash Flow

USD

DarioHealth Corp. produced -25.34M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -136,000.00 in capital expenditures, free cash flow totaled -25.48M - equivalent to -3.92 per share.

Operating Cash Flow-25.34M
Capital Expenditures-136,000.00
Free Cash Flow-25.48M
FCF Per Share-3.92

Margins

Over the twelve months ended June 30, 2026, DarioHealth Corp. posted a gross margin of 58.15, reflecting its pricing power and cost economics. The operating margin of -151.60 and net profit margin of -169.87 provide insight into operational efficiency.

Gross Margin58.15
Operating Margin-151.60
Pretax Margin-167.64
Profit Margin-169.87
EBITDA Margin-249.13

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 21.22 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -59.46: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -35.85, meaning DarioHealth Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Payout Ratio21.22
Shareholder Yield-35.85
FCF Yield-59.46

Stock Splits

DarioHealth Corp.'s most recent stock split took place on August 28, 2025 with a 20:1 split ratio.

Last Split Date8/28/2025
Split Ratio20:1

Scores

As of June 30, 2026, DarioHealth Corp. has an Altman Z-Score of -29.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-29.29